{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:38:17Z","timestamp":1777901897674,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000278","name":"Department for International Development, UK Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009131","name":"Direktion f\u00fcr Entwicklung und Zusammenarbeit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001791","name":"Griffith University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001791","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008196","name":"M\u00e9decins Sans Fronti\u00e8res","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014054","name":"Drugs for Neglected Diseases initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.slasd.2026.100298","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T20:35:59Z","timestamp":1771360559000},"page":"100298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An MRC-5 cell based high-throughput, high-content imaging assay to identify hits against Trypanosoma cruzi intracellular parasites"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5720-4301","authenticated-orcid":false,"given":"Bilal","family":"Zulfiqar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9379-9012","authenticated-orcid":false,"given":"Melissa L.","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9177-9755","authenticated-orcid":false,"given":"Fanny B.","family":"Escudi\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3158-7743","authenticated-orcid":false,"given":"Eric","family":"Chatelain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicky M.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.slasd.2026.100298_bib0001","first-page":"7","article-title":"Chagas disease: from Latin America to the world","author":"Pinazo","year":"2015","journal-title":"Rep Parasitol"},{"issue":"10115","key":"10.1016\/j.slasd.2026.100298_bib0002","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.slasd.2026.100298_bib0003","unstructured":"World health organization (WHO) Chagas disease day 2023. 2023. https:\/\/www.who.int\/campaigns\/world-chagas-disease-day\/2023 (accessed 2025 09.06.2025)."},{"issue":"5","key":"10.1016\/j.slasd.2026.100298_bib0004","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4269\/ajtmh.16-0761","article-title":"Experimental and clinical treatment of Chagas disease: a review","volume":"97","author":"Junior","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.slasd.2026.100298_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112020","article-title":"Advances in the treatment of Chagas disease: promising new drugs, plants and targets","volume":"142","author":"Garc\u00eda-Huertas","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.slasd.2026.100298_bib0006","unstructured":"Murcia, L.; Carrilero, B.; Segovia, M. Limitations of currently available Chagas disease chemotherapy. 2012; Vol. 25, pp 1-3."},{"issue":"10","key":"10.1016\/j.slasd.2026.100298_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.100972","article-title":"Challenges and advancements in the development of vaccines and therapies against Chagas disease","volume":"5","author":"Pinazo","year":"2024","journal-title":"Lancet Microbe"},{"issue":"10","key":"10.1016\/j.slasd.2026.100298_bib0008","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/17512433.2018.1509704","article-title":"Clinical and pharmacological profile of benznidazole for treatment of Chagas disease","volume":"11","author":"M\u00fcller Kratz","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.slasd.2026.100298_bib0009","series-title":"Antiprotozoal Drug Development and Delivery","first-page":"49","article-title":"Chagas disease: drug development and parasite targets","author":"Vermelho","year":"2022"},{"key":"10.1016\/j.slasd.2026.100298_bib0010","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.3389\/fimmu.2018.02791","article-title":"Disease tolerance and pathogen resistance genes may underlie Trypanosoma cruzi persistence and differential progression to Chagas disease cardiomyopathy","volume":"9","author":"Chevillard","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.slasd.2026.100298_bib0011","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/17460441.2018.1417380","article-title":"Phenotypic screening approaches for Chagas disease drug discovery","volume":"13","author":"Chatelain","year":"2018","journal-title":"Expert Opin Drug Discov"},{"issue":"10","key":"10.1016\/j.slasd.2026.100298_bib0012","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.drudis.2017.06.004","article-title":"Leishmaniasis drug discovery: recent progress and challenges in assay development","volume":"22","author":"Zulfiqar","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.slasd.2026.100298_bib0013","first-page":"175","article-title":"Drug discovery and development for neglected diseases: the DND i model","author":"Chatelain","year":"2011","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.slasd.2026.100298_bib0014","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1007\/s00436-018-6084-3","article-title":"Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi","volume":"117","author":"Fonseca-Berzal","year":"2018","journal-title":"Parasitol Res"},{"issue":"3","key":"10.1016\/j.slasd.2026.100298_bib0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijpddr.2015.10.001","article-title":"Development and application of a sensitive, phenotypic, high-throughput image-based assay to identify compound activity against Trypanosoma cruzi amastigotes","volume":"5","author":"Sykes","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"12","key":"10.1016\/j.slasd.2026.100298_bib0016","doi-asserted-by":"crossref","first-page":"e3259","DOI":"10.1371\/journal.pntd.0003259","article-title":"High throughput screening for anti\u2013trypanosoma cruzi drug discovery","volume":"8","author":"Alonso-Padilla","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.slasd.2026.100298_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087188","article-title":"An image-based algorithm for precise and accurate high throughput assessment of drug activity against the human parasite Trypanosoma cruzi","volume":"9","author":"Moon","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.slasd.2026.100298_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004584","article-title":"Identification of trypanocidal activity for known clinical compounds using a new Trypanosoma cruzi hit-discovery screening cascade","volume":"10","author":"De Rycker","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.slasd.2026.100298_bib0019","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s42003-025-08386-0","article-title":"Identification of potent inhibitors of Leishmania donovani and Leishmania infantum chagasi, the causative agents of Old and New World visceral leishmaniasis","volume":"8","author":"Zulfiqar","year":"2025","journal-title":"Commun Biol"},{"issue":"3","key":"10.1016\/j.slasd.2026.100298_bib0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0166-6851(85)90073-8","article-title":"In vitro differentiation of Trypanosoma cruzi under chemically defined conditions","volume":"16","author":"Contreras","year":"1985","journal-title":"Mol Biochem Parasitol"},{"issue":"5254","key":"10.1016\/j.slasd.2026.100298_bib0021","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/227168a0","article-title":"Characteristics of a human diploid cell designated MRC-5","volume":"227","author":"Jacobs","year":"1970","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.slasd.2026.100298_bib0022","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2174\/1389201017666160808160513","article-title":"Cell proliferation and cytotoxicity assays","volume":"17","author":"Adan","year":"2016","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"10.1016\/j.slasd.2026.100298_bib0023","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1017\/S0031182000000615","article-title":"The growth of Trypanosoma cruzi in human diploid cells for the production of trypomastigotes","volume":"80","author":"Sanderson","year":"1980","journal-title":"Parasitology"},{"issue":"10","key":"10.1016\/j.slasd.2026.100298_bib0024","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.drudis.2020.07.024","article-title":"High-throughput screening: today\u2019s biochemical and cell-based approaches","volume":"25","author":"Blay","year":"2020","journal-title":"Drug Discov Today"},{"issue":"10","key":"10.1016\/j.slasd.2026.100298_bib0025","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3390\/molecules22101715","article-title":"Screening a natural product-based library against kinetoplastid parasites","volume":"22","author":"Zulfiqar","year":"2017","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.slasd.2026.100298_bib0026","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/17460441.2022.2002843","article-title":"Assay development in leishmaniasis drug discovery: a comprehensive review","volume":"17","author":"Zulfiqar","year":"2022","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.slasd.2026.100298_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fitd.2023.1254061","article-title":"Preclinical data do not support the use of amiodarone or dronedarone as antiparasitic drugs for Chagas disease at the approved human dosing regimen","volume":"4","author":"Francisco","year":"2023","journal-title":"Front Trop Dis"},{"key":"10.1016\/j.slasd.2026.100298_bib0028","first-page":"54","article-title":"Thieno [3, 2-b] pyrrole 5-carboxamides as potent and selective inhibitors of Giardia duodenalis","volume":"23","author":"Hart","year":"2023","journal-title":"Int J Parasitol: Drugs Drug Resist"},{"key":"10.1016\/j.slasd.2026.100298_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2006-7-10-r100","article-title":"CellProfiler: image analysis software for identifying and quantifying cell phenotypes","volume":"7","author":"Carpenter","year":"2006","journal-title":"Genome Biol"},{"issue":"9","key":"10.1016\/j.slasd.2026.100298_bib0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nmeth.4397","article-title":"Data-analysis strategies for image-based cell profiling","volume":"14","author":"Caicedo","year":"2017","journal-title":"Nat Methods"},{"issue":"2","key":"10.1016\/j.slasd.2026.100298_bib0031","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"},{"issue":"10","key":"10.1016\/j.slasd.2026.100298_bib0032","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41579-019-0238-x","article-title":"Protozoan persister-like cells and drug treatment failure","volume":"17","author":"Barrett","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.slasd.2026.100298_bib0033","first-page":"236","article-title":"Recent developments in sterol 14-demethylase inhibitors for Chagas disease","volume":"2","author":"Buckner","year":"2012","journal-title":"Int J Parasitol: Drugs Drug Resist"},{"issue":"20","key":"10.1016\/j.slasd.2026.100298_bib0034","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas' disease","volume":"370","author":"Molina","year":"2014","journal-title":"N Engl J Med"},{"issue":"1-2","key":"10.1016\/j.slasd.2026.100298_bib0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches","volume":"115","author":"Urbina","year":"2010","journal-title":"Acta Trop"},{"issue":"1","key":"10.1016\/j.slasd.2026.100298_bib0036","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/infdis\/jit420","article-title":"New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice","volume":"209","author":"Bustamante","year":"2014","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.slasd.2026.100298_bib0037","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1087057114550585","article-title":"Chagas disease drug discovery: toward a new era","volume":"20","author":"Chatelain","year":"2015","journal-title":"J Biomol Screen"},{"issue":"2","key":"10.1016\/j.slasd.2026.100298_bib0038","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2149\/tmh.32.181","article-title":"Inhibition of Trypanosoma cruzi growth in mammalian cells by nimodipine, with low cytotoxicity to host cells","volume":"32","author":"Hirota","year":"2004","journal-title":"Trop Med Health"},{"issue":"22","key":"10.1016\/j.slasd.2026.100298_bib0039","doi-asserted-by":"crossref","first-page":"8044","DOI":"10.1016\/j.bmc.2010.09.015","article-title":"Anti-leishmanial and anti-trypanosomal activities of 1, 4-dihydropyridines: in vitro evaluation and structure\u2013activity relationship study","volume":"18","author":"Reim\u00e3o","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.slasd.2026.100298_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.617917","article-title":"Combination with tomatidine improves the potency of posaconazole against trypanosoma cruzi","volume":"11","author":"Rocha-Hasler","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.slasd.2026.100298_bib0041","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-0134(199601)24:1<73::AID-PROT5>3.0.CO;2-P","article-title":"Crystal structure of the Trypanosoma cruzi trypanothione reductase\u00b7 mepacrine complex","volume":"24","author":"Jacoby","year":"1996","journal-title":"Proteins: Struct Funct Bioinform"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555226000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555226000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:13:32Z","timestamp":1777634012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555226000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":41,"alternative-id":["S2472555226000043"],"URL":"https:\/\/doi.org\/10.1016\/j.slasd.2026.100298","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An MRC-5 cell based high-throughput, high-content imaging assay to identify hits against Trypanosoma cruzi intracellular parasites","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.slasd.2026.100298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening.","name":"copyright","label":"Copyright"}],"article-number":"100298"}}